Schwab Charles Investment Management Inc. Acquires 17,600 Shares of RTI Surgical Inc (RTIX)

Schwab Charles Investment Management Inc. lifted its holdings in RTI Surgical Inc (NASDAQ:RTIX) by 16.3% in the 2nd quarter, HoldingsChannel reports. The fund owned 125,900 shares of the medical equipment provider’s stock after buying an additional 17,600 shares during the quarter. Schwab Charles Investment Management Inc.’s holdings in RTI Surgical were worth $580,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the company. Rutabaga Capital Management LLC MA grew its holdings in RTI Surgical by 22.4% during the 2nd quarter. Rutabaga Capital Management LLC MA now owns 1,375,290 shares of the medical equipment provider’s stock valued at $6,326,000 after purchasing an additional 251,894 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in RTI Surgical by 3.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 4,427,446 shares of the medical equipment provider’s stock valued at $20,366,000 after purchasing an additional 160,134 shares in the last quarter. JPMorgan Chase & Co. grew its holdings in RTI Surgical by 204.0% during the 1st quarter. JPMorgan Chase & Co. now owns 44,163 shares of the medical equipment provider’s stock valued at $204,000 after purchasing an additional 29,634 shares in the last quarter. Citadel Advisors LLC acquired a new stake in RTI Surgical during the 1st quarter valued at $130,000. Finally, MetLife Investment Advisors LLC grew its holdings in RTI Surgical by 245.9% during the 1st quarter. MetLife Investment Advisors LLC now owns 28,338 shares of the medical equipment provider’s stock valued at $130,000 after purchasing an additional 20,146 shares in the last quarter. 68.72% of the stock is owned by institutional investors.

A number of equities research analysts recently weighed in on the stock. Zacks Investment Research raised shares of RTI Surgical from a “hold” rating to a “buy” rating and set a $5.25 price target for the company in a report on Tuesday, August 7th. BidaskClub raised shares of RTI Surgical from a “sell” rating to a “hold” rating in a report on Tuesday, July 3rd. Finally, ValuEngine raised shares of RTI Surgical from a “hold” rating to a “buy” rating in a report on Monday, July 2nd.

RTIX opened at $4.57 on Friday. The firm has a market cap of $303.58 million, a P/E ratio of 91.20 and a beta of 1.40. RTI Surgical Inc has a twelve month low of $3.85 and a twelve month high of $5.10. The company has a quick ratio of 1.55, a current ratio of 3.86 and a debt-to-equity ratio of 0.30.

RTI Surgical (NASDAQ:RTIX) last released its quarterly earnings results on Thursday, August 2nd. The medical equipment provider reported $0.03 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.01 by $0.02. The business had revenue of $70.69 million during the quarter, compared to analyst estimates of $70.09 million. RTI Surgical had a net margin of 1.23% and a return on equity of 3.04%. Equities analysts forecast that RTI Surgical Inc will post 0.11 earnings per share for the current year.

RTI Surgical Company Profile

RTI Surgical, Inc, together with its subsidiaries, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It processes donated human musculoskeletal and other tissues, as well as bovine and porcine animal tissues to produce allograft and xenograft implants by using its proprietary BIOCLEANSE, TUTOPLAST, and CANCELLE SP sterilization processes.

Recommended Story: Understanding Compound Annual Growth Rate (CAGR)

Want to see what other hedge funds are holding RTIX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for RTI Surgical Inc (NASDAQ:RTIX).

Institutional Ownership by Quarter for RTI Surgical (NASDAQ:RTIX)

Receive News & Ratings for RTI Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply